Category: News

Researchers from Embryotox, the Berlin TIS, have published their data concerning maternal fosfomycin use in pregnancy. More information can be found here. Photo by Cassidy Rowell on Unsplash

Associate ENTIS member Dr Michael Ceulemans and collegues from KU Leuven in Belgium have published a retrospective analysis of the pregnancy and lactation related enquiries made to the national poison centre between January 2012 and December 2017. More information can be found here. Photo by Berkeley Communications on Unsplash

Researchers from Embryotox, the Berlin TIS, have recently published the results of their systematic review focussing on the risk of prenatal ductus arteriosus constriction, oligohydramnios, neonatal renal failure and primary pulmonary hypertension following maternal short-term use of NSAIDs in the second trimester of pregnancy. More information can be found here.

Researchers from the University of Southern Denmark have undertaken an analysis of the risk of congenital malformation among infants born to women who used antibiotics in pregnancy using data from Danish national health and civic registries. More information can be found here. Photo by freestocks.org on Unsplash

Researchers from Katholieke Universiteit Leuven in Belgium describe their experience of how Arabic-speaking pregnant women with a migration background living in Belgium are likely at risk of receiving incomplete advice regarding medicines use in pregnancy due to language barriers. More information can be found here. Photo by Rob Curran on Unsplash

Researchers from Denmark have explored perceptions of pregnant women regarding medication use during pregnancy. More information can be found here. Photo by bruce mars on Unsplash

Pregnancy labelling of medications is a hotly debated issue in the field of teratology, and several studies have shown the limitations of providing pregnancy safety category ratings for medicines. In this recent academic highlights article, the authors summarise discussions which were held at an April 2017 meeting focussed on pregnancy pharmacogivilance and the FDAs pregnancy and lactation labelling rule. Further […]

Researchers from Boston have reviewed the important methodological considerations regarding the use of large healthcare utilization databases for drug safety surveillance in pregnancy. More information can be found here.   Photo by Hans-Peter Gauster on Unsplash

Researchers from Lyon have updated the 1995 meta-analysis of neural tube defect risk following clomiphene use which found a non-significant increased risk. More information can be found here.

Researchers from the ENTIS Paris COCHIN Center (Centre Régional de Pharmacovigilance et d’information sur le médicament) at the Assistance Publique-Hopitaux de Paris have published national surveillance data of first-trimester exposure to dolutegravir, raltegravir or elvitegravir in pregnancy, adding to the growing body of evidence available for integrase strand transfer inhibitors. More information can be found here.